WallStreetZenWallStreetZen

NASDAQ: BDSX
Biodesix Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their BDSX stock forecasts and price targets.

Forecast return on equity

Is BDSX forecast to generate an efficient return?

Forecast return on assets

Is BDSX forecast to generate an efficient return on assets?
Company
N/A
Industry
3.36%

BDSX revenue forecast

What is BDSX's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$50.2M+13.96%
Avg 2 year Forecast
$62.8M+42.62%
Avg 3 year Forecast
$77.4M+75.92%
BDSX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BDSX revenue growth forecast

How is BDSX forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
19.98%
Industry
-0.1%
Market
6.55%
BDSX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BDSX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BDSX vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
BDSX$1.50N/AN/A
FONR$19.55N/AN/A
NVTA$0.51$0.40-21.57%Strong Sell
GTH$3.69N/AN/A
BNR$0.89N/AN/A
View Top Diagnostic & Research Stocks

Biodesix Stock Forecast FAQ

What is BDSX's revenue growth forecast for 2023-2025?

(NASDAQ: BDSX) Biodesix's forecast annual revenue growth rate of 19.98% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of -0.1%, and it is also forecast to beat the US market's average forecast revenue growth rate of 6.55%.

Biodesix's revenue in 2023 is $44,026,000.On average, 2 Wall Street analysts forecast BDSX's revenue for 2023 to be $4,539,195,720, with the lowest BDSX revenue forecast at $4,523,814,750, and the highest BDSX revenue forecast at $4,554,667,167. On average, 2 Wall Street analysts forecast BDSX's revenue for 2024 to be $5,680,825,610, with the lowest BDSX revenue forecast at $5,564,292,143, and the highest BDSX revenue forecast at $5,797,449,555.

In 2025, BDSX is forecast to generate $7,007,298,571 in revenue, with the lowest revenue forecast at $7,007,298,571 and the highest revenue forecast at $7,007,298,571.

If you're new to stock investing, here's how to buy Biodesix stock.

What is BDSX's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: BDSX) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 3.36%.

What is BDSX's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: BDSX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.